Clinical Trial Update: Immune Response to a Delayed Second Dose of Oral Cholera Vaccine [Phase 4]

View source ↗

Summary

Phase 4 trial update examining the immune response to a delayed second dose of an oral cholera vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholera
• Vibrio Cholerae Infection

Snippet

Sponsor: Epicentre | Conditions: Cholera, Vibrio Cholerae Infection | Phase 4 | Status: UNKNOWN